GENEVA, Aug. 31 -- CURIA BUFFALO R&D, LLC filed a patent application (US2026/015731) for “PREPARATION OF 3,4-DIHYDROQUINOLIN-2(1H)-ONE COMPOUNDS AS ARTEMIS ENDONUCLEASE INHIBITORS”. With publication no. WO/2026/178171, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07D 471/04

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....